The project’s aim is to design maritime platforms able to produce hydrogen, generated with the help of green energies. The platforms could be used to provide service to oil tankers or to fix even fish farming, among others potential uses.
Sant Joan de Déu Hospital in Greater Barcelona has become the first facility in the world to assist a woman who lost her two ovaries to get pregnant. A decade ago she had to have her ovaries completely removed because of two tumours. Ovarian...
Catalonia is fast becoming an international reference point in research projects thanks mainly to a large number of articles being produced and exchange initiatives with other countries being set up. Catalan research centres, especially medical...
The Parkinson symptoms detector device will help patients fight the degenerative disease and improve their quality of life. The system, partly created by Catalan researchers, now needs to be tested on four volunteer patients from around...
The brain damage a foetus may suffer during pregnancy is sometimes not detected in the first few years of a child's life. If that damage could be detected early, psychological stimulation could reduce future learning disorders. Scientists from...
The Spanish IT multinational company Intel and the Barcelona Supercomputing Center will create a joint research and development lab to calculate speeds on the exaFLOP scale, which are a thousand times quicker than the current fastest computers...
The last ‘SCImago Institutions Ranking’ classified the 3,000 best research institutions in the world. Harvard University tops the ranking, but the Catalan institute, is ranked second in Spain and among the best European research centres....
For the first time in the world, a foetus having the spina bifida congenital disorder went through a new intra-uterus surgery technique. A medical team from Barcelona’s Vall d’Hebron Hospital operated on the foetus in its 24th week by...
The vaccine MVA-B against HIV gets a 90% immune response in its first test with humans. In addition, after a year, the vaccine proves to still be effective in 85% of the individuals. The vaccine is still a prototype but it shows a promising...
